Please login to the form below

Not currently logged in
Email:
Password:

IOmet

This page shows the latest IOmet news and features for those working in and with pharma, biotech and healthcare.

Merck & Co buys another immuno-oncology target

Merck & Co buys another immuno-oncology target

Other deals have included the acquisitions of IOmet last year, cCAM Biotherapeutics in 2015 and OncoEthix a year earlier.

Latest news

  • Merck & Co buys IOmet to boost immuno-oncology tech Merck & Co buys IOmet to boost immuno-oncology tech

    Merck &Co buys IOmet to boost immuno-oncology tech. Reports suggest it paid up to £280m for the Scottish biopharma company. ... IOmet will become a wholly owned subsidiary of Merck after the transaction goes through, according to Merck.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics